ME in Parliament: 28 April, 29 April and 1 May

Circulated by Dr. Marc-Alexander Fluks

Source: UK House of Commons
Date: April 28, 2008

URL: http://www.publications.parliament.uk/pa/cm200708/cmhansrd/cm080428/text/80428w0010.htm
Ref: http://www.me-net.combidom.com/meweb/web1.4.htm#westminster

[Written Answers]

Incapacity Benefits: Medical Examinations
—————————————–

Dr. Gibson

To ask the Secretary of State for Work and Pensions what steps he is taking to ensure that employment and support allowance assessments take account of the characteristics of different health conditions, with particular reference to the fluctuations inherent in symptomatic severity of myalgic encephalopathy; and if he will make a statement. [201834]

Mr. Timms

The new Work Capability Assessment for Employment and Support Allowance will be a fair, robust and accurate assessment of limited capability for work which takes account of all conditions, including those that are long term and that fluctuate such as myalgic encephalopathy.

The Work Capability Assessment is not a snapshot of a person’s condition on the day of the assessment. In assessing whether a person can carry out any given activity, health care professionals must take into account the person’s condition over a reasonable period of time. They must take into account the effects of symptoms such as pain and fatigue. In this way the Work Capability  Assessment takes account of the effects of fluctuating conditions.

If there is a change in a person’s disabling condition, there will be a provision to refer the person to an approved healthcare professional so that we can determine afresh whether or not the person has limited capability for work, or limited capability for work-related activity.

——–
(c) 2008 Parliamentary copyright

Source: UK House of Commons
Date: April 29, 2008

URL: http://www.publications.parliament.uk/pa/cm200708/cmhansrd/cm080429/text/80429w0001.htm
Ref: http://www.me-net.combidom.com/meweb/web1.4.htm#westminster

[Written Answers]

Chronic Fatigue Syndrome
————————

Mr. Burstow

To ask the Secretary of State for Health what steps his Department plans to take to ensure that recommendations for research into myalgic encephalomyelitis/chronic fatigue syndrome set out in the National Institute for Health and Clinical Excellence guidelines are met in respect of (a) the causes of the illness, (b) the clinical and cost effectiveness of intervention strategies and (c) identifying efficient ways to deliver domiciliary care for people who are severely affected. [201793]
Dawn Primarolo

Research recommendations made in National Institute for Health and Clinical Excellence (NICE guidelines are considered on behalf of the Department by the National Institute for Health Research Health Technology Assessment programme (HTA). The director of the HTA programme meets annually with NICE for this purpose. The next of these joint meetings will be held in September.

——–
(c) 2008 Parliamentary copyright

Source: UK House of Commons
Date: May 1, 2008

URL: http://www.publications.parliament.uk/pa/cm200708/cmhansrd/cm080501/text/80501w0003.htm
Ref: http://www.me-net.combidom.com/meweb/web1.4.htm#westminster

[Written Answers]

Incapacity Benefits: Chronic Fatigue Syndrome
———————————————

Dr. Gibson

To ask the Secretary of State for Work and Pensions if he will review the process by which assessments are made of whether people with myalgic encephalopathy may receive benefits; what account the process takes of the rate of successful appeals against decisions to deny benefits in such cases; and if he will make a statement. [201837]

Mrs. McGuire

We have already reviewed the process for assessing whether people with medical conditions, including myalgic encephalopathy, may receive incapacity benefits.

The new work capability assessment for employment and support allowance will be a fair, robust and accurate assessment of limited capability for work which takes account of all conditions, including those that are long-term and that fluctuate such as myalgic encephalopathy.

Updated medical guidance on myalgic encephalopathy for disability living allowance decision makers was published in July 2007. There are no current plans for further revision of the process.

The process for employment and support allowance and disability living allowance does not take account of the rate of successful appeals. However, we will continue to monitor new research and evidence, including relevant case law, in this area.

——–
(c) 2008 Parliamentary copyright

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s